Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 2261 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

OKYO Pharma to Reschedule Key Opinion Leader Event in Dry Eye Disease to May 2024

Read more ››
By: GlobeNewswire - 09 Apr 2024
Related companies:  OKYO Pharma Limited

Adcentrx Therapeutics Appoints Meng Jiang as Chief Financial Officer

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024
Related companies:  Adcentrx Therapeutics

COVID-19 Virus Can Persist in the Body More Than a Year after Infection

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024

Longeveron Announces Pricing of $5.25 Million Public Offering

Read more ››
By: GlobeNewswire - 08 Apr 2024
Related companies:  Longeveron Inc.

Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial

Read more ››
By: GlobeNewswire - 08 Apr 2024
Related companies:  Kineta, Inc.

Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study

Read more ››
By: GlobeNewswire - 08 Apr 2024
Related companies:  Shockwave Medical, Inc.

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study

Read more ››
By: GlobeNewswire - 08 Apr 2024
Related companies:  Cardiff Oncology, Inc.

Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights

Read more ››
By: GlobeNewswire - 08 Apr 2024
Related companies:  Cue Biopharma, Inc.

Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Read more ››
By: GlobeNewswire - 08 Apr 2024
Related companies:  Century Therapeutics, Inc.

CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.

Read more ››
By: GlobeNewswire - 08 Apr 2024
Related companies:  Societal CDMO Inc.

IBEX Completes Sale of the Company

Read more ››
By: GlobeNewswire - 08 Apr 2024
Related companies:  IBEX Technologies Inc.

iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting

Read more ››
By: GlobeNewswire - 08 Apr 2024
Related companies:  iCAD, Inc.

Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology Platform

Read more ››
By: GlobeNewswire - 08 Apr 2024
Related companies:  Theratechnologies Inc.

Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual Meeting

Read more ››
By: GlobeNewswire - 08 Apr 2024
Related companies:  Cellectis Inc.

Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 

Read more ››
By: GlobeNewswire - 08 Apr 2024
Related companies:  Vincerx Pharma, Inc.

Onco360 Has Been Selected as the Sole National Specialty Pharmacy Partner for Voydeya® (danicopan)

Read more ››
By: GlobeNewswire - 08 Apr 2024

Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing

Read more ››
By: GlobeNewswire - 08 Apr 2024
Related companies:  Windtree Therapeutics, Inc.

Premier Health Announces the Appointment of Bruno Morel as its New CTO

Read more ››
By: GlobeNewswire - 08 Apr 2024
Related companies:  Premier Health of America Inc.

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS

Read more ››
By: PR Newswire Association LLC. - 08 Apr 2024
Related companies:  CASI Pharmaceuticals, Inc.

Nested Therapeutics Announces Oral Presentation of Preclinical Data for NST-628, a Novel, Fully Brain-Penetrant, Pan-RAF/MEK Molecular Glue, at the 2024 AACR Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 08 Apr 2024
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑